Search

Your search keyword '"Mego, David"' showing total 10 results
Start Over Author "Mego, David" Search Limiters Full Text
10 results on '"Mego, David"'

2. CRT-200.08 Paclitaxel-Eluting Stents in the Superficial Femoral Artery at 12-Month Follow-Up Are Associated With Persistent Inflammation

Author

Shaar, Mohammad, primary, Lendel, Vasili, additional, Hoyt, Taylor, additional, Marmagkiolis, Konstantinos, additional, Ates, Ismail, additional, Mego, David, additional, Paixao, Andre, additional, Park, Jongwan, additional, Mcelroy, Austin, additional, Dijkstra, Jouke, additional, Avci, Recep, additional, Milner, Thomas, additional, Feldman, Marc, additional, and Cilingiroglu, Mehmet, additional

Published
2019
Full Text
View/download PDF

3. CLINICAL OUTCOMES TO 4 YEARS IN PATIENTS IMPLANTED WITH BIOABSORBABLE POLYMER SYNERGY VERSUS PERMANENT POLYMER EVEROLIMUS-ELUTING STENTS: THE EVOLVE II RANDOMIZED TRIAL

Author

Jobe, Robert, primary, Windecker, Stephan, additional, Loli, Akil, additional, Mego, David, additional, Ando, Kenji, additional, Muramatsu, Toshiya, additional, Stammen, Francis, additional, Curtis, Michael, additional, Helqvist, Steffen, additional, Christen, Thomas, additional, Allocco, Dominic, additional, Meredith, Ian, additional, and Kereiakes, Dean, additional

Published
2018
Full Text
View/download PDF

4. SAFETY AND EFFECT ON HEALTHCARE EXPENSES WITH SAME VERSUS NEXT DAY DISCHARGE AFTER ELECTIVE TRANSRADIAL PERCUTANEOUS CORONARY INTERVENTION

Author

Rodriguez-Araujo, Gerardo, primary, Rollefson, William, additional, Cilingiroglu, Mehmet, additional, Mego, David, additional, Cawich, Ian, additional, Lendel, Vasili, additional, Paixao, Andre, additional, Marmagkiolis, Konstantinos, additional, Sherbet, Daniel, additional, and Flaherty, Patrick, additional

Published
2017
Full Text
View/download PDF

5. LBT-7 Feasibility And Clinical Importance Of Same Versus Next Day Discharge After Elective Transradial Percutaneous Coronary Intervention, The Rasadda-pci Trial

Author

Rollefson, William, primary, Cilingiroglu, Mehmet, additional, Mego, David, additional, Cawich, Ian, additional, Lendel, Vasili, additional, Paixao, Andre, additional, Marmagkiolis, Konstantinos, additional, Sherbet, Daniel, additional, Flaherty, Patrick, additional, and Rodriguez-Araujo, Gerardo, additional

Published
2017
Full Text
View/download PDF

7. THE 2.25 MILLIMETER XIENCE V® EVEROLIMUS ELUTING CORONARY STENT SYSTEM FOR THE TREATMENT OF SMALL CORONARY ARTERIES: THE SPIRIT SMALL VESSEL TRIAL

Author

Costa, Marco A., primary, Jones, Jennifer, additional, Fleischhauer, F. James, additional, Cheong, Wai-Fung, additional, Kusano, Hajime, additional, Farhat, Naim, additional, Wang, Jin, additional, Lombardi, William, additional, Zhang, Zhen, additional, Maddux, James, additional, Mego, David, additional, Li, Xiaolin, additional, Cannon, Louis, additional, Hattori, Kyoko, additional, Foster, Malcolm T., additional, Sood, Poornima, additional, and Simon, Daniel, additional

Published
2011
Full Text
View/download PDF

9. MitraClip Deployed via Left Femoral Vein in an 85-Year-Old Woman with Mitral Regurgitation

Author

Deniz Mutlu, David Mego, Mehmet Cilingiroglu, Kostas Marmagkiolis, Mohan Mallikarjuna Rao Edupuganti, Çilingiroğlu, Mehmet, Edupuganti, Mohan Mallikarjuna Rao, Mutlu, Deniz, Mego, David M., Marmagkiolis, Kostas, School of Medicine, Department of Cardiology, and İÜC, Cerrahpaşa Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü

Subjects
medicine.medical_specialty, heart failure/therapy, Femoral vein, Case Reports, heart valve prosthesis implantation/methods, 030204 cardiovascular system & hematology, 03 medical and health sciences, cardiac catheterization/instrumentation/standards, 0302 clinical medicine, Medicine, Cardiac and cardiovascular systems, Mitral valve, medicine, Aged, 80 and over, Balloon valvuloplasty/ methods, Cardiac catheterization/ instrumentation/ standards, Femoral vein/ surgery, Heart failure/ therapy, Heart valve diseases/ complications, Heart valve prosthesis implantation/ methods, Mitral valve insufficiency/ therapy, Punctures/ methods, Treatment outcome, In patient, 030212 general & internal medicine, punctures/methods, Mitral regurgitation, balloon valvuloplasty/methods, femoral vein/surgery, business.industry, MitraClip, Open surgery, heart valve diseases/complications, Blood flow, Surgery, medicine.anatomical_structure, Left femoral vein, treatment outcome, cardiovascular system, Cardiology and Cardiovascular Medicine, business, mitral valve insufficiency/therapy
Abstract

The MitraClip system can be used to control regurgitant blood flow in patients with mitral regurgitation who cannot tolerate open surgery to replace the mitral valve. Technical limitations make the right femoral vein the standard access point for placing the MitraClip. However, this route is not always suitable. We present the case of an 85-year-old woman in whom we successfully used a left-sided approach for inserting a MitraClip because her right femoral vein was occluded. This apparently novel left femoral approach merits consideration as an option for device insertion when right femoral vein access is precluded., NA

Published
2019

10. A poly-N-acetyl glucosamine hemostatic dressing for femoral artery access site hemostasis after percutaneous coronary intervention: a pilot study.

Author

Mego D, Thomas M, Stewart J, Rollefson W, Flaherty P, Murphy B, and Ribeiro P

Subjects
Acetylglucosamine administration & dosage, Acetylglucosamine adverse effects, Administration, Topical, Aged, Anticoagulants therapeutic use, Female, Hemostatics administration & dosage, Hemostatics adverse effects, Hirudins, Humans, Male, Peptide Fragments therapeutic use, Pilot Projects, Recombinant Proteins therapeutic use, Retrospective Studies, Thrombosis prevention & control, Time Factors, Walking, Acetylglucosamine therapeutic use, Angioplasty, Balloon, Coronary methods, Biological Dressings, Femoral Artery physiology, Hemostasis physiology, Hemostatics therapeutic use, Regional Blood Flow physiology
Abstract

Background: Arterial puncture closure devices have improved time to hemostasis and ambulation after percutaneous coronary intervention (PCI) relative to traditional manual compression, though complication rates for both methods leave room for improvement. In a pilot registry, the authors evaluated a topical hemostatic dressing containing poly-N-acetyl glucosamine (p-GlcNAc) post PCI in fully anticoagulated patients., Methods and Results: In 100 patients undergoing PCI via the common femoral artery in the short-stay unit, the p-GlcNAc hemostatic dressing was applied with 15 minutes of manual compression at arterial access sites after arterial sheath removal. Procedural antiplatelet and anticoagulation therapies were aspirin, clopidogrel and bivalirudin. Patients were observed during 2 hours of bed rest and attempted to ambulate 2 hours post hemostasis. Effectiveness was assessed based on times to hemostasis and ambulation. Data were stratified by time elapsed since bivalirudin bolus or discontinuation of infusion (30 minutes, > 30-60 minutes, > 60 minutes). Mean time to hemostasis was 15.5 minutes. Mean time from hemostasis to ambulation was 2.08 hours; 87% of patients ambulated at 2 hours. Sheaths were removed at a mean 40.38 minutes after discontinuing bivalirudin. Anticoagulation status (as assessed by time since discontinuation of bivalirudin) did not influence time to hemostasis or ambulation. There was a single major complication (pseudoaneurysm), two minor rebleeds requiring additional manual compression, and 1 hematoma > 5 cm., Conclusions: This p-GlcNAc topical hemostatic dressing safely achieved hemostasis at arterial access sites and early ambulation, even with nearly immediate sheath removal after PCI with systemic anticoagulation using bivalirudin.

Published
2010

Catalog

Books, media, physical & digital resources
See catalog results